Back to top

Image: Shutterstock

3 Stocks With Superb Earnings Acceleration to Buy Before 2027

Read MoreHide Full Article

Key Takeaways

  • AnaptysBio, Ensign Group and CEVA show accelerating quarterly EPS growth and carry a Zacks Rank #2.
  • AnaptysBio leads the three picks with an expected current-year earnings growth rate of 913%.
  • Ensign Group and CEVA project current-year earnings growth of 21.2% and 26.2%, respectively.

While consistent earnings growth reflects a company’s solid profitability, earnings acceleration acts as a powerful indicator of future stock price gains. Historical market studies show that many top-performing stocks show earnings acceleration before their share prices begin a significant upward trend.

On that note, AnaptysBio, Inc. (ANAB - Free Report) , The Ensign Group, Inc. (ENSG - Free Report) and CEVA, Inc. (CEVA - Free Report) are showing strong earnings acceleration and upside potential, making them compelling buys ahead of the new year. Each of these stocks currently carries a Zacks Rank #2 (Buy). You can see the complete list of today’s Zacks #1 Rank (Strong Buy) stocks here. 

Understanding Earnings Acceleration: Key Insights for Investors 

Earnings acceleration refers to the incremental growth in a company’s earnings per share (EPS). Put simply, if a company’s quarter-over-quarter earnings growth rate increases over a given period, it is considered earnings acceleration. 

With earnings growth, you pay for something already reflected in the stock price. However, earnings acceleration helps identify stocks that haven’t yet caught investors’ attention and, once secured, will invariably lead to a rally in share price. This is because earnings acceleration considers both the direction and magnitude of growth rates. 

An increasing percentage of earnings growth means that the company is fundamentally sound and has been on the right track for a considerable period. Meanwhile, a sideways percentage of earnings growth indicates a period of consolidation or slowdown, while a decelerating percentage of earnings growth may drag prices down. 

Identify Potential Winning Stocks Faster With Research Wizard 

Look at stocks for which the last two quarter-over-quarter percentage EPS growth rates exceed the previous periods’ growth rates. The projected EPS growth rate for the upcoming quarter is expected to exceed that of prior periods. 

EPS % Projected Growth (Q1)/(Q0) greater than EPS % Growth (Q0)/(Q-1): The projected growth rate for the current quarter (Q1) over the completed quarter (Q0) has to be greater than the growth rate from the completed quarter (Q0) over one quarter ago (Q-1). 

EPS % Growth (Q0)/(Q-1) greater than EPS % Growth (Q-1)/(Q-2): The growth rate for the completed quarter (Q0) over one quarter ago (Q-1) has to be greater than the growth rate from one quarter ago (Q-1) over two quarters ago (Q-2). 

EPS % Growth (Q-1)/(Q-2) greater than EPS % Growth (Q-2)/(Q-3): The growth rate from one quarter ago (Q-1) over two quarters ago (Q-2) has to be greater than the growth rate from two quarters ago (Q-2) over three quarters ago (Q-3). 

In addition to this, we have added the following parameters: 

Current Price greater than or equal to $5: This screens out low-priced stocks.

Average 20-day volume greater than or equal to 50,000: High trading volume implies that the stocks have adequate liquidity.

The above criteria narrowed the universe of around 7,735 stocks to only six. Here are the top three stocks: 

AnaptysBio 

AnaptysBio discovers and develops therapeutic antibodies in the United States. ANAB’s expected earnings growth rate for the current year is 913%.

Ensign Group 

Ensign Group delivers skilled nursing care, senior living solutions and rehabilitation services. ENSG’s expected earnings growth rate for the current year is 21.2%.

CEVA 

CEVA provides silicon and software IP solutions to semiconductor and electronics manufacturers worldwide. CEVA’s expected earnings growth rate for the current year is 26.2%.

Published in